Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.

Wang J, Zhang Z, Li R, Sun W, Chen J, Zhang H, Shu K, Lei T.

Life Sci. 2018 Feb 1;194:150-156. doi: 10.1016/j.lfs.2017.12.037. Epub 2017 Dec 27.

PMID:
29288766
2.

ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion.

Cesarini V, Silvestris DA, Tassinari V, Tomaselli S, Alon S, Eisenberg E, Locatelli F, Gallo A.

Nucleic Acids Res. 2018 Feb 28;46(4):2045-2059. doi: 10.1093/nar/gkx1257.

3.

ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.

Wang J, Zhang Z, Li R, Mao F, Sun W, Chen J, Zhang H, Bartsch JW, Shu K, Lei T.

Biomed Pharmacother. 2018 Jan;97:1066-1077. doi: 10.1016/j.biopha.2017.11.034. Epub 2017 Nov 9.

PMID:
29136943
4.

ADAM12-deficient zebrafish exhibit retardation in body growth at the juvenile stage without developmental defects.

Tokumasu Y, Iida A, Wang Z, Ansai S, Kinoshita M, Sehara-Fujisawa A.

Dev Growth Differ. 2016 May;58(4):409-21. doi: 10.1111/dgd.12286. Epub 2016 May 16.

PMID:
27185351
5.

miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.

Lulli V, Buccarelli M, Martini M, Signore M, Biffoni M, Giannetti S, Morgante L, Marziali G, Ilari R, Pagliuca A, Larocca LM, De Maria R, Pallini R, Ricci-Vitiani L.

Oncotarget. 2015 Nov 10;6(35):37241-56. doi: 10.18632/oncotarget.5925.

6.

ADAM12 and ADAM17 are essential molecules for hypoxia-induced impairment of neural vascular barrier function.

Cui D, Arima M, Takubo K, Kimura T, Horiuchi K, Minagawa T, Matsuda S, Ikeda E.

Sci Rep. 2015 Aug 5;5:12796. doi: 10.1038/srep12796.

7.

Effects of nitric oxide synthase deficiency on a disintegrin and metalloproteinase domain-containing protein 12 expression in mouse brain samples.

Lendeckel U, Wolke C, Bernstein HG, Keilhoff G.

Mol Med Rep. 2015 Aug;12(2):2253-62. doi: 10.3892/mmr.2015.3643. Epub 2015 Apr 17.

PMID:
25892053
8.

ADAM 12: a putative marker of oligodendrogliomas?

Kanakis D, Lendeckel U, Theodosiou P, Dobrowolny H, Mawrin C, Keilhoff G, Bukowska A, Dietzmann K, Bogerts B, Bernstein HG.

Dis Markers. 2013;34(2):81-91. doi: 10.3233/DMA-120953.

9.

Quantitative and dynamic expression profile of premature and active forms of the regional ADAM proteins during chicken brain development.

Markus A, Yan X, Rolfs A, Luo J.

Cell Mol Biol Lett. 2011 Sep;16(3):431-51. doi: 10.2478/s11658-011-0016-x. Epub 2011 Jul 18.

10.

Molecular characterization and expression analysis of ADAM12 during chicken embryonic development.

Lin J, Luo J, Redies C.

Dev Growth Differ. 2010 Dec;52(9):757-69. doi: 10.1111/j.1440-169X.2010.01212.x.

PMID:
21158755
11.

Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia.

Farkas N, Lendeckel U, Dobrowolny H, Funke S, Steiner J, Keilhoff G, Schmitt A, Bogerts B, Bernstein HG.

World J Biol Psychiatry. 2010 Apr;11(3):556-66. doi: 10.3109/15622970903497936.

PMID:
20218926
12.

ADAM12 is expressed by astrocytes during experimental demyelination.

Baertling F, Kokozidou M, Pufe T, Clarner T, Windoffer R, Wruck CJ, Brandenburg LO, Beyer C, Kipp M.

Brain Res. 2010 Apr 22;1326:1-14. doi: 10.1016/j.brainres.2010.02.049. Epub 2010 Feb 20.

PMID:
20176000
13.

LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology.

Owuor K, Harel NY, Englot DJ, Hisama F, Blumenfeld H, Strittmatter SM.

Mol Cell Neurosci. 2009 Dec;42(4):448-57. doi: 10.1016/j.mcn.2009.09.008. Epub 2009 Sep 29.

14.

Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis.

Wang X, Oka T, Chow FL, Cooper SB, Odenbach J, Lopaschuk GD, Kassiri Z, Fernandez-Patron C.

Hypertension. 2009 Sep;54(3):575-82. doi: 10.1161/HYPERTENSIONAHA.108.127670. Epub 2009 Jul 6.

PMID:
19581512
15.

Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.

Zubel A, Flechtenmacher C, Edler L, Alonso A.

Gynecol Oncol. 2009 Aug;114(2):332-6. doi: 10.1016/j.ygyno.2009.05.005. Epub 2009 May 27.

PMID:
19473694
16.

Differential expression of five members of the ADAM family in the developing chicken brain.

Lin J, Luo J, Redies C.

Neuroscience. 2008 Nov 19;157(2):360-75. doi: 10.1016/j.neuroscience.2008.08.053. Epub 2008 Sep 4.

PMID:
18832016
17.

Fibroblast growth factor induces a neural stem cell phenotype in foetal forebrain progenitors and during embryonic stem cell differentiation.

Pollard SM, Wallbank R, Tomlinson S, Grotewold L, Smith A.

Mol Cell Neurosci. 2008 Jul;38(3):393-403. doi: 10.1016/j.mcn.2008.03.012. Epub 2008 Apr 10.

PMID:
18504136
18.

GABA receptors ameliorate Hcy-mediated integrin shedding and constrictive collagen remodeling in microvascular endothelial cells.

Shastry S, Tyagi N, Moshal KS, Lominadze D, Hayden MR, Tyagi SC.

Cell Biochem Biophys. 2006;45(2):157-65.

19.

Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activity.

Malinin NL, Wright S, Seubert P, Schenk D, Griswold-Prenner I.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3058-63. Epub 2005 Feb 14.

20.

ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.

Kodama T, Ikeda E, Okada A, Ohtsuka T, Shimoda M, Shiomi T, Yoshida K, Nakada M, Ohuchi E, Okada Y.

Am J Pathol. 2004 Nov;165(5):1743-53.

Supplemental Content

Loading ...
Support Center